Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03811795 · ClinicalTrials.gov registry record · NA
Cryoballoon vs. Rhythmia Guided Ablation for Recurrent AFib
A NA study, sponsored by Valley Health System.
- Completed
- Registry status
- NA
- Development phase
- 9
- Enrollment target
NCT03811795: Completed NA study, sponsored by Valley Health System.
NCT03811795 is a NA study that has completed, run by Valley Health System. The registered enrollment target is 9 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (99% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03811795, a NA study, has completed, sponsored by Valley Health System.
- COMPLETED
- Registry status
- NA
- Development phase
- 9 participants
- Enrollment target
Study Summary
The purpose of this research is to evaluate whether cryoballoon ablation vs. radiofrequency ablation guided by high-fidelity mapping (Rhythmia) is the best treatment strategy to perform repeat ablation for recurrent atrial fibrillation after previously having undergone cryoballoon ablation.
Primary Outcome
The freedom from atrial fibrillation at 6 months is the primary endpoint. The presence or absence of atrial fibrillation will be assessed during the study period.
Interventions
- OTHER ECG monitoring with a Kardia Mobile monitor
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 9 participants |
| Start Date | 2018-11-27 |
| Est. Completion | 2022-04-26 |
| Phase | NA |
What the finished NCT03811795 record still lists
NCT03811795 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 9 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (99% lower).
The record links to 0 conditions, and to 1 intervention - of which ECG monitoring with a Kardia Mobile monitor is the first listed.
NCT03811795 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT03811795 about?
NCT03811795 is a clinical study titled "Cryoballoon vs. Rhythmia Guided Ablation for Recurrent AFib". The purpose of this research is to evaluate whether cryoballoon ablation vs. radiofrequency ablation guided by high-fidelity mapping (Rhythmia) is the best treatment strategy to perform repeat ablation for recurrent atrial fibrillation after previously having undergone cryoballoon ablation.
What is the current status of trial NCT03811795?
This trial is currently completed. It is a NA study. The enrollment target is 9 participants. The study started on 2018-11-27. Estimated completion is 2022-04-26.
What interventions are being tested in trial NCT03811795?
The interventions under investigation include: ECG monitoring with a Kardia Mobile monitor (OTHER).
Who is sponsoring clinical trial NCT03811795?
This trial is sponsored by Valley Health System, which has 8 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT03811795's enrollment target sits among peer trials
9 1975th of 2000 higher than 25 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI